Kintara Therapeutics, Inc. operates as a clinical and commercial stage drug development company with a focus on the treatment of cancer. The Company focuses on identifying clinical and commercial-stage compounds and establishing a scientific rationale for development in modern orphan drug indications. Kintara Therapeutics serves customers worldwide. Show more
Location: 12707 High Bluff Drive, Suite 200, California, 92130, US | Website: www.kintara.com | Industry: Polish and Other Sanitation Good Manufacturing | Sector: Manufacturing
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$2.61
Open
$2.69
Volume
601,379
Day Range
$2.15 - $2.74
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.12%
Institutional Own.
1.47%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
REM-001 Details Metastatic breast cancer, Cancer | Phase 2/3 Data readout | |
IFX-Hu2.0 Details Cancer, Metastatic merkel cell carcinoma, Cutaneous squamous cell carcinoma | Phase 1b Update | |
VAL-083 Details Glioblastoma, Cancer | Failed Discontinued |